冷冻消融在肺癌治疗中的研究进展

doi:10.3760/cma.j.issn.1673-422X.2019.07.008

摘要/Abstract

摘要： 目前已有临床研究证实，冷冻消融是一种安全有效的肺癌治疗方案。冷冻消融已临床应用于各种类型的肺癌治疗中，并且取得了较好的治疗效果。冷冻消融出现的一些并发症在给予对症治疗后多可缓解。然而，冷冻消融在临床应用中仍需进一步研究探索。

关键词: 肺肿瘤, 冷冻外科手术

Abstract: Clinical studies have confirmed that cryoablation is a safe and effective treatment for lung cancer. Cryoablation has been clinically used in the treatment of various types of lung cancer, and has achieved good therapeutic effects. Some of the complications of cryoablation can be alleviated after symptomatic treatment. However, cryoablation still needs further research and exploration in clinical applications.

Key words: Lung neoplasms, Cryosurgery

马远坤，倪吉祥，赵天明，胡学华，杨玉婷. 冷冻消融在肺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2019, 46(7): 427-429.

Ma Yuankun, Ni Jixiang, Zhao Tianming, Hu Xuehua, Yang Yuting. Research progress of cryoablation in the treatment of lung cancer[J]. Journal of International Oncology, 2019, 46(7): 427-429.

参考文献

［1］ Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin, 2018, 68(6): 394424. DOI: 10.3322/caac.21492. ［2］麦泽锋. 消癌平注射液联合多西他赛治疗晚期非小细胞肺癌的临床观察［J］. 国际肿瘤学杂志, 2017, 44(7): 557558. DOI: 10.3760/cma.j.issn.1673422X.2017.07.021. ［3］ Jia B, Zheng Q, Qi X, et al. Survival comparison of right and left side nonsmall cell lung cancer in stage ⅠⅢA patients: a surveillance epidemiology and end results (SEER) analysis［J］. Thorac Cancer, 2019, 10(3): 459471. DOI: 10.1111/17597714.12959. ［4］ Knavel EM, Brace CL. Tumor ablation: common modalities and general practices［J］. Tech Vasc Interv Radiol, 2013, 16(4): 192200. DOI: 10.1053/j.tvir.2013.08.002. ［5］ Mehta A, Oklu R, Sheth RA. Thermal ablative therapies and immune checkpoint modulation: can locoregional approaches effect a systemic response?［J］. Gastroenterol Res Pract, 2016, 2016: 9251375. DOI: 10.1155/2016/9251375. ［6］ Abdo J, Cornell DL, Mittal SK, et al. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers［J］. Front Oncol, 2018, 8: 85. DOI: 10.3389/fonc.2018.00085. ［7］ Yamauchi Y, Izumi Y, Hashimoto K, et al. Percutaneous cryoablation for the treatment of medically inoperable stage Ⅰ nonsmall cell lung cancer［J］. PLoS One, 2012, 7(3): e33223. DOI: 10.1371/journal.pone.0033223. ［8］ Moore W, Talati R, Bhattacharji P, et al. Fiveyear survival after cryoablation of stage Ⅰ nonsmall cell lung cancer in medically inoperable patients［J］. J Vasc Interv Radiol, 2015, 26(3): 312319. DOI: 10.1016/j.jvir.2014.12.006. ［9］ Sharma A, Abtin F, Shepard JA. Imageguided ablative therapies for lung cancer［J］. Radiol Clin North Am, 2012, 50(5): 975999. DOI: 10.1016/j.rcl.2012.06.004. ［10］赵丹, 乔炳礼, 李润花, 等. 氩氦刀冷冻消融联合化疗治疗非小细胞肺癌的疗效及对相关癌性疼痛的影响［J］. 实用医学杂志, 2016, 32(21): 34793482. DOI: 10.3969/j.issn.10065725.2016.21.005. ［11］孔小锋, 姚飞, 陈继冰, 等. 经皮联合支气管腔内冷冻消融治疗中央型肺癌的研究分析［J］. 中华肺部疾病杂志(电子版), 2014, 7(2): 174178. DOI: 10.3969/cma.j.issn.16746902.2014.02.011. ［12］ Ridge CA, Solomon SB. Percutaneous ablation of colorectal lung metastases［J］. J Gastrointest Oncol, 2015, 6(6): 685692. DOI: 10.3978/j.issn.20786891.2015.095. ［13］ Ridge CA, Solomon SB, Thornton RH. Thermal ablation of stage Ⅰ nonsmall cell lung carcinoma［J］. Semin Intervent Radiol, 2014, 31(2): 118124. DOI: 10.1055/s00341373786. ［14］ Yamauchi Y, Izumi Y, Kawamura M, et al. Percutaneous cryoablation of pulmonary metastases from colorectal cancer［J］. PLoS One, 2011, 6(11): e27086. DOI: 10.1371/journal.pone.0027086. ［15］ de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients—safety and efficacy: the ECLIPSE trial—interim analysis at 1year［J］. J Thorac Oncol, 2015, 10(10): 14681474. DOI: 10.1097/JTO.0000000000000632. ［16］ Zappa C, Mousa SA. Nonsmall cell lung cancer: current treatment and future advances［J］. Transl Lung Cancer Res, 2016, 5(3): 288300. DOI: 10.21037/tlcr.2016.06.07. ［17］ Zhang M, Guo H, Zhao S, et al. Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced nonsmall cell lung cancer: a metaanalysis of randomized controlled trials［J］. Oncotarget, 2016, 7(26): 3982339833. DOI: 10.18632/oncotarget.9503. ［18］ Yang Y, Zhang B, Li R, et al. EGFRtyrosine kinase inhibitor treatment in a patient with advanced nonsmall cell lung cancer and concurrent exon 19 and 21 EGFR mutations: a case report and review of the literature［J］. Oncol Lett, 2016, 11(5): 35463550. DOI: 10.3892/ol.2016.4409. ［19］ Gao W, Guo Z, Shu S, et al. The application effect of percutaneous cryoablation for the stage ⅢB/Ⅳ advanced nonsmallcell lung cancer after the failure of chemoradiotherapy［J］. Asian J Surg, 2018, 41(6): 530536. DOI: 10.1016/j.asjsur.2018.02.006. ［20］洪超煜, 梅同华, 王进. 化疗间插联合EGFRTKIs对比单独化疗一线治疗晚期非小细胞肺癌的meta分析［J］. 中国肺癌杂志, 2016, 19(12): 837846. DOI: 10.3779/j.issn.10093419.2016.12.06. ［21］ Chang TC, Chin YT, Nana AW, et al. Enhancement by nanodiaminotetrac of antiproliferative action of gefitinibon colorectal cancer cells: mediation by EGFR sialylation and PI3K activation［J］. Horm Cancer, 2018, 9(6): 420432. DOI: 10.1007/s126720180341x. ［22］ Sohn HS, Kwon JW, Shin S, et al. Effect of smoking status on progressionfree and overall survival in nonsmall cell lung cancer patients receiving erlotinib or gefitinib: a metaanalysis［J］. J Clin Pharm Ther, 2015, 40(6): 661671. DOI: 10.1111/jcpt.12332. ［23］ Gu XY, Jiang Z, Fang W. Cryoablation combined with molecular target therapy improves the curative effect in patients with advanced nonsmall cell lung cancer［J］. J Int Med Res, 2011, 39(5): 17361743. DOI: 10.1177/147323001103900516. ［24］ Inoue M, Nakatsuka S, Jinzaki M. Cryoablation of earlystage primary lung cancer［J］. Biomed Res Int, 2014, 2014: 521691. DOI: 10.1155/2014/521691. ［25］ Chou HP, Chen CK, Shen SH, et al. Percutaneous cryoablation for inoperable malignant lung tumors: midterm results［J］. Cryobiology, 2015, 70(1): 6065. DOI: 10.1016/j.cryobiol.2014.12.004. ［26］ Abdo J, Cornell DL, Mittal SK, et al. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers［J］. Front Oncol, 2018, 8: 85. DOI: 10.3389/fonc.2018.00085.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[3]	贺嘉慧, 胡钦勇. 基于GBD数据的中国和美国肺癌发病和死亡趋势及危险因素对比分析[J]. 国际肿瘤学杂志, 2024, 51(1): 29-36.
[4]	李雄安, 颜艳艳. 丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192.
[5]	左小平, 刘晓川, 吴西强, 李周, 夏天, 刘国凤. 老年早期肺癌患者经胸腔镜肺切除术后心律失常发生的危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(12): 711-716.
[6]	陈郁, 许华, 刘海, 陈士新. 基于CT影像学特征的恶性肺纯磨玻璃结节患者病理分型预测模型构建[J]. 国际肿瘤学杂志, 2023, 50(11): 655-660.
[7]	张万芳, 王尤, 苏晶, 陈刚, 周福祥. 肺原发尤文肉瘤/原始神经外胚层瘤1例[J]. 国际肿瘤学杂志, 2023, 50(1): 62-64.
[8]	杨莎, 杨晓华, 王苏华, 薛晓燕, 徐俊. 老年肺癌胸腔镜手术后下肢深静脉血栓的危险因素分析及预测模型的建立和验证[J]. 国际肿瘤学杂志, 2022, 49(9): 532-536.
[9]	王津, 张耀圣, 孙婷婷, 王丹, 胡乃东. 以前胸壁聚集性多发蕈状肿物为表现的肺腺鳞状细胞癌皮肤转移1例[J]. 国际肿瘤学杂志, 2022, 49(9): 575-576.
[10]	陈煌婧, 朱鹏飞, 张晴, 陈桂芳, 杨春林, 何英. 超声造影和CT引导下经皮穿刺活检在周围型肺肿块诊断中临床价值的比较[J]. 国际肿瘤学杂志, 2022, 49(8): 459-463.
[11]	蔡刚祥, 李境, 许斌. 肺癌新辅助免疫治疗研究进展[J]. 国际肿瘤学杂志, 2022, 49(6): 366-370.
[12]	韩丛丛, 付帅, 谢超, 张建军, 张秋景, 祝情情, 刘杰. 吉非替尼、培美曲塞和贝伐珠单抗一线治疗EGFR突变晚期肺腺癌的有效性和安全性[J]. 国际肿瘤学杂志, 2022, 49(6): 376-379.
[13]	王永洪, 何弢, 李星, 罗启余, 王乔羽. 信迪利单抗致晚期鳞状细胞肺癌患者致死性中毒性表皮坏死松解症1例[J]. 国际肿瘤学杂志, 2022, 49(6): 380-382.
[14]	张静娴, 易丹, 李小江. 抗体偶联药物在非小细胞肺癌中的应用[J]. 国际肿瘤学杂志, 2022, 49(5): 296-301.
[15]	高敏, 冯静, 王丽, 钟海, 文昱婷, 万兵, 张秀伟. 微生物群与肺癌的早期诊断及辅助治疗[J]. 国际肿瘤学杂志, 2022, 49(4): 247-251.